Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
42,833,193
-
Total 13F shares
-
41,392,949
-
Share change
-
+737,287
-
Total reported value
-
$20,147,440,124
-
Put/Call ratio
-
91%
-
Price per share
-
$487.25
-
Number of holders
-
811
-
Value change
-
+$444,501,681
-
Number of buys
-
427
-
Number of sells
-
310
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2025
As of 31 Dec 2025,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
811 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,392,949 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and ASSETMARK, INC.
This page lists
811
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.